| Title |
Author |
Type |
Date |
Words |
| New Evidence on Role of Food in Gastrointestinal Disorders. |
|
|
May 7, 2013 |
831 |
| Analysis of the Expanding U.S. Market for Gastrointestinal Disorders Prescription Pharmaceuticals. |
|
|
Apr 3, 2013 |
1781 |
| ASKTHEEXPERTS. |
|
|
Apr 1, 2013 |
290 |
| Turning Attention to Returning Vets During IBS Awareness Month. |
|
|
Apr 1, 2013 |
816 |
| Butt Sports to clash with Saliheen in final. |
|
|
Mar 30, 2013 |
267 |
| CBK, IBS organize good governance program. |
|
|
Mar 24, 2013 |
253 |
| What's up Doc? Check out our questions and answers; From irritable bowel syndrome and cystitis to bladder weakness and piles, we will probably all experience some form of condition connected with the bladder or the bowels at some point in our lives. Dr Charlotte Jones, who sits on the British Medical Association Cymru's GP's committee, looks at these common conditions and answers some of the questions often asked by patients. |
|
|
Mar 18, 2013 |
1883 |
| Dietary changes help those with irritable bowel syndrome: irritable bowel syndrome may affect around 20 per cent of the population and can be a very difficult health problem to treat. Recent research at a nurse-led service in Christchurch has reported some encouraging improvements in patient symptoms. |
Moore, Judy |
|
Mar 1, 2013 |
2683 |
| Finding and treating the unrecognized cause of inflammation. |
|
|
Mar 1, 2013 |
1429 |
| Saliheen wins thriller to enter semis; IBS stuns Hyderabad Green. |
|
|
Mar 1, 2013 |
462 |
| Salix Pharmaceuticals Reports 4Q2012 and FY2012 Results. |
|
Financial report |
Feb 28, 2013 |
10771 |
| MarketResearchReports Publishes Gastrointestinal Disorders Therapeutics Market to 2018. |
|
|
Feb 23, 2013 |
569 |
| NANEO Precision IBS Coatings GmbH Expands Manufacturing Capacity with Veeco IBD System. |
|
|
Feb 15, 2013 |
501 |
| IBS, N.A. Commences $350MM Distressed Real Estate Fund. |
|
|
Feb 13, 2013 |
455 |
| Frost & Sullivan finds Significant Unmet Therapeutic Need for two Key Bowel Disorders across the U.S. |
|
|
Feb 5, 2013 |
1158 |
| Frost & Sullivan finds Significant Unmet Therapeutic Need for two Key Bowel Disorders across the U.S. |
|
|
Feb 5, 2013 |
1168 |
| Small intestine bacterial overgrowth: often-ignored cause of irritable bowel syndrome. |
Siebecker, Allison; Sandberg-Lewis, Steven |
|
Feb 1, 2013 |
6565 |
| How Do You Know If You Have IBS? |
|
|
Jan 28, 2013 |
1056 |
| How Do You Know If You Have IBS? |
|
|
Jan 28, 2013 |
1060 |
| Research and Markets: Analysis of the Expanding U.S. Market for Gastrointestinal Disorders Prescription Pharmaceuticals. |
|
|
Jan 24, 2013 |
734 |
| GE's Newest Appliances at IBS Simplify Chores and Offer Technology-Rich Features. |
|
|
Jan 23, 2013 |
544 |
| Aquasana Introduces Four New Showstoppers at IBS. |
|
|
Jan 22, 2013 |
847 |
| Panasonic Showcases New Dual Voltage Technology For Tough IP(TM) Power Tools At IBS 2013. |
|
|
Jan 22, 2013 |
1765 |
| Integrated biosystems. |
Kavishe, Daniel |
|
Jan 11, 2013 |
500 |
| Constella/Linzess Will Achieve Blockbuster Sales of $1.2 Billion in 2021 in the Irritable Bowel Syndrome Drug Market. |
|
|
Dec 19, 2012 |
570 |
| Lexicon's Drug Candidate For Irritable Bowel Syndrome Receives Fast Track Status From The FDA. |
|
|
Dec 17, 2012 |
752 |
| Ironwood and Forest Announce U.S. Availability of LINZESS[TM] (Linaclotide). |
|
|
Dec 17, 2012 |
1596 |
| Constella (linaclotide) Approved in Europe for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)in Adults. |
|
|
Nov 28, 2012 |
2525 |
| Irritable bowel syndrome not 'all in the head'. |
|
|
Nov 18, 2012 |
241 |
| Research and Markets: Irritable Bowel Syndrome - Pipeline Review, H2 2012. |
|
|
Nov 16, 2012 |
453 |
| Research and Markets: Global Irritable Bowel Syndrome Epidemiology and Patient Flow Analysis - 2012. |
|
Clinical report |
Nov 12, 2012 |
318 |
| Research and Markets: Gastrointestinal Disorders Therapeutics Market to 2018 - Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and Ulcerative Colitis (UC) to Reinvigorate the Market. |
|
|
Nov 2, 2012 |
634 |
| Ways to ease the pain of IBS. |
|
|
Oct 30, 2012 |
339 |
| Ways to ease the pain of IBS; health focus. |
|
|
Oct 30, 2012 |
340 |
| Innovative Technologies and Endoscopic Techniques to Treat Gastrointestinal Disorders; New Insight on Esophageal and Colorectal Cancers; Trends in C. difficile, GI Bleeding Mortality Among Featured Topics Presented at the American College of Gastroenterology's 77th Annual Meeting. |
|
|
Oct 23, 2012 |
3596 |
| What the experts says about IBS. |
|
|
Oct 23, 2012 |
199 |
| The hardest thing about IBS? No chocs; ME AND MY HEALTH.. ZOE SALMON. |
|
|
Oct 23, 2012 |
980 |
| Innovative Technologies and Endoscopic Techniques to Treat Gastrointestinal Disorders. |
|
|
Oct 19, 2012 |
3617 |
| Watching what you eat and drinkin n ng hot water instead of coffee might be boring but it beats being in ag g gony every day; ACTRESS KAREN DUNBAR FOUND LIFESTYLE CHANGES WERE BEST FOR DEALING WITH THE PAIN OF IRRITABLE BOWEL SYNDROME. |
|
Theater review |
Oct 2, 2012 |
1406 |
| Research and Markets: Irritable Bowel Syndrome (Event Driven). |
|
|
Sep 25, 2012 |
254 |
| Linaclotide Receives Positive CHMP Opinion for the Treatment of IBS-C. |
|
|
Sep 21, 2012 |
1557 |
| Research and Markets: Global Irritable Bowel Syndrome Drug Pipeline Capsule - 2012 Update Provides Information on Pipeline Molecules by Company and Mechanism of Action. |
|
|
Sep 17, 2012 |
300 |
| Research and Markets: Global Irritable Bowel Syndrome Drug Pipeline Capsule - 2012. |
|
|
Sep 12, 2012 |
417 |
| Drug to treat constipation gains FDA approval. |
|
|
Aug 31, 2012 |
173 |
| United States : Ironwood And Forest Announce Fda Approval Of Linzesstm (linaclotide) For The Treatment Of Irritable Bowel Syndrome With Constipation And Chronic Idiopathic Constipation. |
|
|
Aug 31, 2012 |
361 |
| Ironwood and Forest Announce FDA Approval of LINZESSTM (Linaclotide) for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation. |
|
|
Aug 30, 2012 |
2952 |
| FEELGUT FACTOR; pounds 2 probiotic drink to beat bowel hell. |
|
|
Aug 1, 2012 |
265 |
| 2 pounds probiotic drink may help beat 'bowel hell'. |
|
|
Aug 1, 2012 |
247 |
| Low-FODMAPs diet for irritable bowel syndrome. |
Gaby, Alan R. |
|
Aug 1, 2012 |
320 |
| Illumina Countersues IBS and Qiagen for Patent Infringement. |
|
|
Jul 23, 2012 |
498 |
| ASKTHEEXPERTS. |
|
|
Jul 16, 2012 |
331 |
| Cases of bowel disease increasing. |
|
|
Jul 16, 2012 |
333 |
| 'Six sugars' diet offers hope for people who can't digest fructose. |
|
|
Jul 8, 2012 |
498 |
| Cultured milk cure. |
Edwards, Laura |
Brief article |
Jul 1, 2012 |
216 |
| Irritable bowel syndrome in children explained: gastrointestinal symptoms may indicate irritable bowel syndrome and management in children should be considered with care. |
Read, Nick |
Disease/Disorder overview |
Jul 1, 2012 |
946 |
| Furiex Pharmaceuticals Announces First Patient Dosed in Phase III Clinical Trials of MuDelta in Diarrhea-Predominant Irritable Bowel Syndrome. |
|
|
Jun 19, 2012 |
911 |
| The connection between your gut and brain. |
|
|
Jun 13, 2012 |
786 |
| Research and Markets: Irritable Bowel Syndrome Global Clinical Trials Review, H1, 2012. |
|
|
Jun 8, 2012 |
322 |
| Pilot study of natural therapies to improve gluten sensitivities. |
Wise, Jack; Block, J. E. |
Clinical report |
Jun 1, 2012 |
2159 |
| Antibiotics, probiotics are options for IBS treatment. |
Jancin, Bruce |
|
Jun 1, 2012 |
362 |
| Antibiotics/probiotics called helpful in IBS. |
Jancin, Bruce |
|
Jun 1, 2012 |
398 |
| Bacterial overgrowth in gut ups Irritable bowel syndrome. |
|
|
May 27, 2012 |
402 |
| Bacteria in gut 'play role in irritable bowel syndrome'. |
|
|
May 27, 2012 |
402 |
| AltheRx Presents Positive Phase II Results of Solabegron in Overactive Bladder at the American Urological Association Annual Meeting. |
|
Clinical report |
May 21, 2012 |
608 |
| Sucampo Presents Data for AMITIZA[R] in the Treatment of Moderate to Very Severe Irritable Bowel Syndrome with Constipation (IBS-C). |
|
|
May 20, 2012 |
1431 |
| Ocera Therapeutics receives CE Mark for Zysa(TM) for the treatment of diarrhea-predominant Irritable Bowel Syndrome (IBS-d). |
|
|
May 18, 2012 |
838 |
| Surveyed U.S. Gastroenterologists and MCO Pharmacy Directors Say Improvement in Overall Symptoms of IBS Remains a Significant Unmet Need; Asimadoline, Mudelta and LX-1033 Have Demonstrated the Potential to Partially Fulfill This Unmet Need. |
|
|
May 9, 2012 |
657 |
| Egypt : Haier Group inks distribution deal with IBS in Egypt. |
|
|
May 8, 2012 |
195 |
| Ajinomoto Pharmaceuticals/Albireo Sign License Pact. |
|
|
May 1, 2012 |
740 |
| Support for IBS Sufferers as COLPERMIN[R] IBS Relief Launches an IBS Advice Centre. |
|
|
Apr 25, 2012 |
698 |
| Tioga Pharmaceuticals Raises $10 Million to Advance Phase 3 Clinical Development of Asimadoline in Irritable Bowel Syndrome. |
|
|
Apr 12, 2012 |
708 |
| Ajinomoto Pharmaceuticals and Albireo Announce Japan and Asia License Agreement for Elobixibat. |
|
|
Apr 3, 2012 |
868 |
| Hypnosis provides lasting relief from bowel disorder symptoms. |
|
|
Apr 3, 2012 |
450 |
| 10 ways to beat IBS. |
|
|
Apr 3, 2012 |
607 |
| Food sensitivities, probiotics, and IBS. |
Klotter, Jule |
|
Apr 1, 2012 |
660 |
| IBS patients 'have higher prevalence of traumatic childhood experiences'. |
|
|
Mar 30, 2012 |
367 |
| Drugs best suited for treating Irritable Bowel Syndrome identified. |
|
|
Mar 26, 2012 |
359 |
| Research and Markets: Irritable Bowel Syndrome - Pipeline Review, H1 2012. |
|
|
Mar 23, 2012 |
399 |
| Melatonin and irritable bowel syndrome. |
Patrick, Regina |
|
Mar 22, 2012 |
1015 |
| April Is IBS Awareness Month: Calling Attention to a Serious Issue for Returning Veterans. |
|
|
Mar 21, 2012 |
617 |
| IBS Direct Announces Acquisition of Imtek, LLC. |
|
|
Mar 20, 2012 |
504 |
| Phase 3 Long-Term Safety Trial Results of Lubiprostone in Patients with Irritable Bowel Syndrome with Constipation was Recently Published in Alimentary Pharmacology and Therapeutics. |
|
|
Mar 6, 2012 |
1197 |
| AltheRx Presents Positive Phase II Results of Solabegron in Overactive Bladder at the European Association of Urology Congress. |
|
Clinical report |
Mar 1, 2012 |
607 |
| Salix Pharmaceuticals Announces Initiation of Target 3: A Phase 3 Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550MG TID in Subjects with Irritable Bowel Syndrome with Diarrhea. |
|
|
Feb 21, 2012 |
1550 |
| Whirlpool Corporation Helps Builders Create Homes of Distinction at 2012 IBS. |
|
|
Feb 8, 2012 |
1043 |
| Deceuninck North America Highlights Success of Comprehensive Recycling Program for Customers During IBS 2012. |
|
|
Feb 6, 2012 |
498 |
| NAHB IBS 2012: AdvantageLumber.com to Showcase the Latest in Exotic Hardwood Decking & Lumber Products. |
|
|
Feb 2, 2012 |
484 |
| Pathogenic bacteria associated with GI symptoms in parasite-free patients. |
Amin, Omar M. |
Report |
Jan 1, 2012 |
2837 |
| Novel 'FODMAP' diet may tame irritable bowel syndrome. |
Splete, Heidi |
|
Jan 1, 2012 |
662 |
| Actinidic archaea and viroids related hepato-gastrointestinal syndrome. |
Kurup A., Ravikumar; Kurup, Parameswara Achutha |
Report |
Dec 31, 2011 |
4256 |
| Clinically proven herbs for every day gastrointestinal challenges. |
Boyd, Michelle |
|
Dec 22, 2011 |
686 |
| Management of IBS. |
Murphy, Kathleen |
Report |
Dec 22, 2011 |
622 |
| Linaclotide Will Become the New Market Leader and Achieve Blockbuster Status by 2018 for the Treatment of Irritable Bowel Syndrome. |
|
|
Dec 22, 2011 |
587 |
| Stomach grumbles may indicate more than indigestion. |
|
|
Dec 22, 2011 |
204 |
| Banking Studies-Harvard program to improve bank management - CBK. |
|
|
Dec 18, 2011 |
404 |
| Research and Markets: Irritable Bowel Syndrome Epidemiology by Sub-Type in G7 Countries. |
|
|
Dec 16, 2011 |
363 |
| Nutritional considerations in massage. |
Cartmell, John W. |
|
Dec 1, 2011 |
1425 |
| Research and Markets: Irritable Bowel Syndrome - Pipeline Review, Q1 2011. |
|
|
Nov 30, 2011 |
418 |
| FDA Advisory Committee Supports Proposed Clinical Trial Design to Evaluate Repeat Treatment Cycles of XIFAXAN[R] for Irritable Bowel Syndrome with Diarrhea. |
|
|
Nov 16, 2011 |
1423 |
| Salix Pharmaceuticals Reports 3Q2011 Results and Raises 2011 Guidance. |
|
Financial report |
Nov 8, 2011 |
15103 |
| Lifetime psychological traumas may lead to irritable bowel syndrome. |
|
|
Nov 1, 2011 |
233 |
| Ironwood and Forest to Present Linaclotide Results from Phase 2B and Phase 3 Trials in Patients with Irritable Bowel Syndrome with Constipation or Chronic Constipation. |
|
Clinical report |
Oct 27, 2011 |
946 |
| HEALTH OUR expert; Clinical director of the Independent General Practice answers your. |
|
|
Oct 26, 2011 |
606 |
| Ironwood and Forest Announce Linaclotide New Drug Application for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Constipation Accepted for FDA Review. |
|
|
Oct 24, 2011 |
874 |
| Research and Markets: Irritable Bowel Syndrome - Pipeline Review, H2 2011. |
|
|
Oct 19, 2011 |
394 |
| 'I don't want anyone to suffer way I did' Jennifer ended up at 6 stone. |
|
|
Oct 15, 2011 |
432 |
| 'Smart pill' hope for IBS sufferers. |
|
|
Oct 6, 2011 |
151 |
| Giardiasis linked to fatigue, IBS 3 years later. |
Smith, Jennie |
|
Oct 1, 2011 |
619 |
| Ironwood Announces Linaclotide European Regulatory Submission for the Treatment of Irritable Bowel Syndrome with Constipation. |
|
|
Sep 29, 2011 |
743 |
| Almirall Announces Regulatory Filing of linaclotide for the Treatment of Irritable Bowel Syndrome With Constipation in Europe. |
|
|
Sep 29, 2011 |
1301 |
| Research and Markets: Global Irritable Bowel Syndrome Drug Pipeline Capsule - 2011 Report Helps Executives to Keep a Track of Their Competitors and Understand Their Pipeline Molecules. |
|
|
Sep 27, 2011 |
403 |
| Research and Markets: the global Irritable Bowel Syndrome (IBS) Therapeutics Market Is Expected To Grow At A Compound Annual Growth Rate (CAGR) Of 11.7% To Reach $1.6 Billion By 2018. |
|
|
Sep 21, 2011 |
300 |
| Negative emotions significantly affect brain processing of pain. |
|
|
Sep 20, 2011 |
249 |
| Research and Markets: Gastrointestinal Disorder Therapeutics Market to 2017 - Crohn's Disease and Irritable Bowel Syndrome Markets Show Strongest Growth. |
|
|
Sep 15, 2011 |
418 |
| Ulcerative colitis, IBS and Crohn's disease segments of gastrointestinal disorder therapeutics market exhibiting rapid growth: companiesandmarkets.com. |
|
|
Sep 13, 2011 |
437 |
| In Praise of Apples, Peppermint, and Walnuts. |
|
|
Sep 1, 2011 |
647 |
| Lexicon Announces Publication of Results From the Phase 2 Trial of LX1031 in Patients With Irritable Bowel Syndrome in Journal of Gastroenterology. |
|
Clinical report |
Aug 10, 2011 |
684 |
| Ironwood and Forest Announce Submission of New Drug Application for Linaclotide for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Constipation. |
|
|
Aug 9, 2011 |
892 |
| Salix Pharmaceuticals Reports 2Q2011 Results. |
|
Financial report |
Aug 8, 2011 |
15342 |
| Is this the miracle cure for your IBS? |
|
|
Aug 4, 2011 |
431 |
| Is this the miracle cure for your IBS? |
|
|
Aug 4, 2011 |
431 |
| Lexicon's IBS Drug Candidate, LX1033, Successfully Completes Phase 1 Clinical Trial. |
|
|
Jul 28, 2011 |
1065 |
| Silicom Announces a Major Design Win for Its Intelligent External BYPASS Switch (IBS). |
|
|
Jul 6, 2011 |
656 |
| Literature review & commentary. |
Gaby, Alan R. |
Report |
Jul 1, 2011 |
2060 |
| New Research Study Concludes That Chronic Abdominal Pain, or IBS - Affecting 15% of Children in the U.S. - is Widely Mistreated With Antidepressants. |
|
|
Jun 30, 2011 |
492 |
| SELF-HELP; LIVING WITH IBS. |
|
|
Jun 28, 2011 |
215 |
| DPS Sharjah boys team reach IBS semi-finals. |
|
|
Jun 3, 2011 |
373 |
| FDA Grants Fast Track Designation to Tioga Pharmaceuticals' Asimadoline for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome. |
|
|
Jun 1, 2011 |
619 |
| IBS to provide iCargo IT system to Cargoitalia. |
|
|
May 18, 2011 |
115 |
| IBS to provide iCargo IT system to Cargoitalia. |
|
|
May 18, 2011 |
114 |
| Salix Pharmaceuticals Reports 1Q2011 Results. |
|
Financial report |
May 5, 2011 |
12029 |
| Ironwood and Forest to Present Linaclotide Results from Phase 3 Trials in Patients with Irritable Bowel Syndrome with Constipation. |
|
|
May 4, 2011 |
1244 |
| Surveyed PCPs Are Significantly More Likely Than Gastroenterologists to Consider Amitiza, Alosetron and Xifaxan to Be Very Effective for Irritable Bowel Syndrome Motility Symptom Management. |
|
|
Apr 11, 2011 |
703 |
| During April, IBS Awareness Month, Be Aware of Signs You Should Not Ignore. |
|
|
Mar 29, 2011 |
574 |
| AltheRx Completes Acquisition of First Product Solabegron from GlaxoSmithKline. |
|
Clinical report |
Mar 24, 2011 |
650 |
| Salix Receives Anticipated FDA Complete Response Letter On XIFAXAN[R] 550 Mg Tablets Non-C IBS Supplemental New Drug Application. |
|
|
Mar 8, 2011 |
1079 |
| Prebiotics and probiotics/Pre ve probiyotikler. |
Kutlu, Tufan |
Report |
Mar 1, 2011 |
4433 |
| Salix Anticipates Receipt of FDA Complete Response Letter on XIFAXAN[R] 550 Mg Tablets Supplemental New Drug Application. |
|
|
Feb 24, 2011 |
1192 |
| Rifaximin may relieve IBS symptoms in some. |
Sullivan, Michele G. |
Clinical report |
Feb 1, 2011 |
1121 |
| Possible relief for an irritable bowel: local-acting antibiotic beats placebo in two clinical trials. |
Seppa, Nathan |
|
Jan 29, 2011 |
433 |
| Exercise may help patients with irritable bowel syndrome. |
|
|
Jan 26, 2011 |
242 |
| Furiex Receives FDA Fast Track Designation of MuDelta for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome. |
|
|
Jan 24, 2011 |
708 |
| Research by the Connecticut Gastroenterology Institute at Bristol Hospital Shows Promising New Treatments for Patients with the Irritable Bowel Syndrome. |
|
|
Jan 6, 2011 |
571 |
| XIFAXAN[R] 550 mg Tablets Demonstrated Significant Acute and Sustained Relief of Irritable Bowel Syndrome Without Constipation According to Findings Published in the New England Journal of Medicine. |
|
|
Jan 5, 2011 |
1502 |
| PCA Economist Sullivan presents tepid residential outlook at IBS. |
|
|
Jan 1, 2011 |
660 |
| For Treatment of Irritable Bowel Syndrome, Linaclotide Will Emerge as the Market Leader and Will Achieve Blockbuster Status in 2019. |
|
|
Dec 16, 2010 |
644 |
| Serotonin synthesis inhibitor improves IBS symptoms. |
Schonfeld, Amy |
|
Dec 1, 2010 |
628 |
| Intelligent Building Solutions, LLC (IBS). |
|
|
Dec 1, 2010 |
143 |
| Novel agent effective in IBS with constipation: improvements reported in first week of therapy; decrease in abdominal pain demonstrated. |
Napoli, Denise |
Report |
Dec 1, 2010 |
691 |
| Bevego Continues to Invest in IBS Enterprise. |
|
|
Nov 18, 2010 |
382 |
| Help for IBS? |
|
Column |
Nov 1, 2010 |
230 |
| Ironwood and Forest Announce Positive Linaclotide Results from Second Phase 3 Trial in Patients with Irritable Bowel Syndrome with Constipation. |
|
|
Nov 1, 2010 |
2724 |
| Almirall and Ironwood Announce Positive Results from the Second Phase 3 Trial of Linaclotide in Patients with Irritable Bowel Syndrome with Constipation. |
|
Financial report |
Nov 1, 2010 |
2008 |
| XIFAXAN 550 mg (Rifaximin) Demonstrates Acute and Sustained Relief of Non-Constipation Irritable Bowel Syndrome Symptoms: Data Presented at the 2010 American College of Gastroenterology (ACG) Annual Meeting. |
|
|
Oct 18, 2010 |
2743 |
| Serotonin synthesis inhibitor helpful for IBS: investigational agent acts on enterochromaffin cells in the GI tract to inhibit tryptophan hydroxylase. |
Schonfeld, Amy |
|
Oct 1, 2010 |
602 |
| Natural Product Shows Promise for Irritable Bowel Syndrome with 99% Success Rate. |
|
|
Sep 21, 2010 |
426 |
| AMRI Advances New Irritable Bowel Syndrome Treatment Toward IND Submission. |
|
|
Sep 14, 2010 |
1088 |
| Almirall and Ironwood Announce Positive Results from a Phase 3 Trial with Linaclotide in Patients with Irritable Bowel Syndrome with Constipation. |
|
|
Sep 13, 2010 |
1833 |
| Ironwood and Forest Announce Positive Linaclotide Results from Phase 3 Trial in Patients with Irritable Bowel Syndrome with Constipation. |
|
|
Sep 13, 2010 |
2672 |
| Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics. |
|
Report |
Sep 1, 2010 |
349 |
| Food hypersensitivity and irritable bowel syndrome. |
|
Report |
Sep 1, 2010 |
144 |
| Food-specific IGG4 antibody-guided exclusion diet improves symptoms and rectal compliance in irritable bowel syndrome. |
|
Report |
Sep 1, 2010 |
255 |
| Highlights from the Mayo Clinic Health Letter August issue: Chronic Constipation; Improving Symptoms of IBS; and Staying Intimate Later in Life. |
|
|
Aug 20, 2010 |
1355 |
| IBS Global Consulting to Launch the Coffee and Culture Breakfast Roundtable Series. |
|
|
Aug 15, 2010 |
427 |
| Salix Announces FDA Acceptance for Filing and Priority Review Designation For XIFAXAN550 sNDA For the Treatment of Non-Constipation Irritable Bowel Syndrome. |
|
|
Aug 9, 2010 |
1182 |
| Salix Pharmaceuticals Reports 2Q2010 Results. |
|
Financial report |
Aug 9, 2010 |
12216 |
| Greenspan's Bookshelf. |
Greenspan, Able |
Recommended readings |
Aug 1, 2010 |
463 |
| FIS Experiences Strong First Half of 2010 with New IBS Core Deals. |
|
|
Jul 19, 2010 |
788 |
| Irritable bowel: 1 in 5 patients uses narcotics for bowel Pain. |
Sullivan, Michele G. |
|
Jul 1, 2010 |
663 |
| Firm enters mission critical facilities arena. |
|
|
Jun 30, 2010 |
444 |
| Gastrointestinal Disorders Therapeutics to 2016 - High Unmet Needs Triggering Strong Growth in Crohn's Disease and Irritable Bowel Syndrome Markets Now Available at ReportsandReports. |
|
|
Jun 28, 2010 |
5669 |
| Gastrointestinal Disorders Therapeutics to 2016 - High Unmet Needs Triggering Strong Growth in Crohn's Disease and Irritable Bowel Syndrome Markets Now Available at ReportsandReports. |
|
|
Jun 28, 2010 |
5607 |
| Delhi Private School clinch IBS League title. |
|
|
Jun 15, 2010 |
353 |
| Salix Pharmaceuticals Announces NDA Submission For XIFAXAN550 For Treatment of Non-Constipation Irritable Bowel Syndrome. |
|
|
Jun 8, 2010 |
930 |
| Tioga Pharmaceuticals Begins Phase 3 Trial of Asimadoline in Irritable Bowel Syndrome. |
|
|
Jun 3, 2010 |
657 |
| Multi-Flora Plus minimizes symptoms of irritable bowel syndrome. |
|
|
Jun 1, 2010 |
121 |
| Functional relaxation as complementary therapy in irritable bowel syndrome. |
Robertshawe, Penny |
Report |
Jun 1, 2010 |
672 |
| Media Prima Berhad Implements Accenture Integrated Broadcast System. |
|
|
May 26, 2010 |
1007 |
| Salix Announces Issuance of U.S. Patent for Rifaximin. |
|
|
May 20, 2010 |
442 |
| Soligenix Announces Grant of US Patent for the Treatment of Irritable Bowel Syndrome with Oral Beclomethasone Dipropionate. |
|
|
May 19, 2010 |
1508 |
| Cognitive behavior therapy may rapidly relieve severe IBS symptoms. |
|
|
May 15, 2010 |
417 |
| Salix Pharmaceuticals Reports 1Q2010 Results. |
|
Financial report |
May 10, 2010 |
1464 |
| First Federal Bank Selects FIS for Core Processing Technology. |
|
|
May 6, 2010 |
781 |
| Lexicon Presents Positive Outcome in IBS Patients Treated With LX1031 and Data Supporting Mechanism of Action. |
|
Clinical report |
May 5, 2010 |
1046 |
| Mayo Clinic Discovers New Genetic Candidates for Irritable Bowel Syndrome. |
|
|
May 4, 2010 |
580 |
| XIFAXAN 550 mg (rifaximin) Demonstrated Acute and Sustained Relief of Non-Constipation Irritable Bowel Syndrome Symptoms; Data from Target 1&2 Presented at Digestive Disease Week (DDW). |
|
|
May 3, 2010 |
2624 |
| Cole Taylor Bank Selects FIS as its Exclusive Provider of Enterprise-Wide Banking and Payments Capabilities. |
|
|
Apr 27, 2010 |
808 |
| For Irritable Bowel Syndrome, a Chronic Problem That's Not Easily Identified, Vidazorb[R] Probiotics Offer a Promising Solution. |
|
Disease/Disorder overview |
Mar 31, 2010 |
376 |
| Symptomatology, Quality of Life and Economic Features of Irritable Bowel Syndrome--The Effect of Hypnotherapy. |
Hartman, David |
Brief article |
Mar 22, 2010 |
302 |
| Hypnotherapy for Irritable Bowel Syndrome: The Response of Colonic and Noncolonic Symptoms. |
Hartman, David |
Brief article |
Mar 22, 2010 |
158 |
| Irritable Bowel Syndrome: Symptomatic Treatment versus Integrative Psychotherapy. |
Hartman, David |
Brief article |
Mar 22, 2010 |
283 |
| Hypnotic Imagery as an Adjunct to Therapy for Irritable Bowel Syndrome: An Experimental Case Report. |
Hartman, David |
Brief article |
Mar 22, 2010 |
171 |
| Where Does Hypnotherapy Stand in the Management of Irritable Bowel Syndrome? A Systematic Review. |
Hartman, David |
Brief article |
Mar 22, 2010 |
120 |
| Effect of Nurse-led Gut-directed Hypnotherapy upon Health-related Quality of Life in Patients with Irritable Bowel Syndrome. |
Hartman, David |
Brief article |
Mar 22, 2010 |
179 |
| Hypnosis Home Treatment for Irritable Bowel Syndrome: A Pilot Study. |
Hartman, David |
Brief article |
Mar 22, 2010 |
183 |
| The Use of Hypnosis for Irritable Bowel Syndrome. |
Hartman, David |
Brief article |
Mar 22, 2010 |
114 |
| Hypnotherapy and Refractory Irritable Bowel Syndrome: A Single Case Study. |
Hartman, David |
Case study |
Mar 22, 2010 |
188 |
| Irritable Bowel Syndrome: Psychosocial Assessment and Treatment. |
Hartman, David |
Abstract |
Mar 22, 2010 |
144 |
| Hypnotherapy Treatment Manual for Irritable Bowel Syndrome. |
Hartman, David |
Abstract |
Mar 22, 2010 |
148 |
| The Treatment of Irritable Bowel Syndrome with Hypnotherapy. |
Hartman, David |
Abstract |
Mar 22, 2010 |
224 |
| Shift workers at increased irritable bowel syndrome risk. |
|
|
Mar 20, 2010 |
341 |
| Hypnotherapy effective for easing irritable bowel syndrome symptoms. |
|
|
Mar 19, 2010 |
308 |
| The Irritable Bowel Syndrome Drug Market Will More Than Triple From $459 Million in 2008 to $1.52 Billion in 2018. |
|
|
Mar 15, 2010 |
630 |
| Irritable bowel syndrome patients not at increased colon cancer risk. |
|
|
Mar 10, 2010 |
295 |
| Salix Pharmaceuticals Reports 4Q2009 and FY2009 Results. |
|
Financial report |
Mar 9, 2010 |
2985 |
| Jarro-Dophilus allergen-free & Ideal Bowel Support (IBS) 299v. |
|
|
Mar 1, 2010 |
122 |
| Extensive work-up for IBS rarely needed. |
Walsh, Nancy |
|
Mar 1, 2010 |
670 |
| Effect of fibre, antispasmodics and peppermint oil on irritable bowel syndrome. |
Robertshawe, Penny |
Report |
Mar 1, 2010 |
633 |
| Neuroendocrinological effects of acupuncture for irritable bowel syndrome. |
Robertshawe, Penny |
Report |
Mar 1, 2010 |
617 |
| Silicom's 10Gbps External Intelligent Bypass Switch (IBS) Selected by Major Application Delivery Solution Company. |
|
|
Feb 22, 2010 |
513 |
| Tioga Pharmaceuticals, Inc. Raises $18 Million to Fund Phase 3 Clinical Trial in Irritable Bowel Syndrome. |
|
|
Feb 17, 2010 |
281 |
| IPO sector: Ironwood Pharmaceuticals Inc. |
|
Brief article |
Feb 8, 2010 |
316 |
| St. John's wort doesn't help patients with irritable bowel syndrome. |
|
|
Jan 6, 2010 |
298 |
| Probiotics in IBS. |
|
Brief article |
Jan 1, 2010 |
253 |
| Which fiber is best for IBS? |
Ebbert, Jon O.; Tangalos, Eric G. |
Clinical report |
Jan 1, 2010 |
843 |
| People thought I was 9 months pregnant but this was ..a 17lb CYST; EXCLUSIVE. |
|
|
Dec 13, 2009 |
473 |
| Salix Pharmaceuticals Reports Concurrence with FDA on Content and Format of the Pending Rifaximin NDA in the Treatment of Non-Constipation Irritable Bowel Syndrome. |
|
|
Dec 10, 2009 |
1227 |
| Soothing those irritable bowels; HEALTH MATTERS YOUR MEDICAL QUERIES ANSWERED. |
|
|
Dec 10, 2009 |
639 |
| Guidelines call for celiac screening in IBS. |
Birk, Susan |
|
Dec 1, 2009 |
798 |
| Sucampo Announces Lubiprostone Data Presented at GASTRO 2009 UEGF/WCOG. |
|
|
Nov 25, 2009 |
1622 |
| PPD and Janssen Pharmaceutica Collaborate to Develop Compounds for Treatment of Irritable Bowel Syndrome and Bacterial Infections. |
|
Clinical report |
Nov 16, 2009 |
685 |
| Salix Pharmaceuticals Reports 3Q2009 Results. |
|
|
Nov 9, 2009 |
2292 |
| Screening for restless legs syndrome warranted in IBS. |
Wendling, Patrice |
|
Nov 1, 2009 |
627 |
| Restless legs syndrome associated with IBS. |
Wendling, Patrice |
Report |
Oct 1, 2009 |
644 |
| Probiotics' effects on irritable bowel syndrome. |
Klotter, Jule |
Report |
Oct 1, 2009 |
523 |
| Chinese medicine: Wu Mei Wan and diarrhea due to irritable bowel syndrome. |
Flaws, Bob |
Report |
Oct 1, 2009 |
1622 |
| Optimizing metabolism: untangling the complexities of irritable bowel syndrome and food reactivities. |
Kohlstadt, Ingrid |
Report |
Oct 1, 2009 |
1374 |
| Naturopathic perspectives: irritable bowel syndrome and a few of my favorite things ... |
Barker, Jason |
Report |
Oct 1, 2009 |
1886 |
| Women's health update: irritable bowel syndrome in women. |
Hudson, Tori |
Report |
Oct 1, 2009 |
3922 |
| Meridian Bioscience Europe Announces Agreement to Distribute Test For GI Disease. |
|
|
Sep 30, 2009 |
836 |
| Salix Pharmaceuticals Announces Statistically Significant Results for Both the Primary and Key Secondary Analyses Of Rifaximin in the Treatment of Non-Constipation Irritable Bowel Syndrome in Two Phase 3 Trials (Target 1 and Target 2). |
|
Financial report |
Sep 14, 2009 |
1402 |
| Research and Markets: An Essential Irritable Bowel Syndrome Therapy Area Pipeline Report. |
|
Report |
Sep 8, 2009 |
356 |
| Soluble fibre 'effective in treating irritable bowel syndrome'. |
|
|
Aug 28, 2009 |
315 |
| Take care over pine nuts if you have an allergy. |
|
|
Aug 18, 2009 |
306 |
| Salix Pharmaceuticals Reports 2Q2009 Results Updates Full Year Guidance. |
|
|
Aug 10, 2009 |
2567 |
| Probiotic ingredient improves digestive health. |
Kiefer, Dale |
Brief article |
Aug 1, 2009 |
161 |
| IRISH GASTROENTEROLOGY RESEARCHERS PIONEER IBS TREATMENTS. |
|
|
Jun 1, 2009 |
891 |
| Direct-to-consumers drug ads may lead to prescription overuse. |
|
|
Jun 1, 2009 |
272 |
| Synergy Pharmaceuticals to Present Phase I Volunteer Study on SP-304 Investigational Drug to Treat GI Disorders at Upcoming Conference. |
|
Conference news |
May 26, 2009 |
572 |
| ASK THE EXPERTS. |
|
|
May 25, 2009 |
393 |
| Gazelles beat Millennium in IBS clash. |
|
|
May 14, 2009 |
228 |
| All Stars grab narrow victory over Hustlers in IBS League. |
|
|
May 12, 2009 |
258 |
| Salix Pharmaceuticals Reports 1Q2009 Results. |
|
Financial report |
May 5, 2009 |
2256 |
| Fiserv Ranked #1 in Anti-Money Laundering System Sales for Second Consecutive Year. |
|
|
Apr 27, 2009 |
310 |
| Zeroz down Miracles in IBS League opener. |
|
|
Apr 20, 2009 |
173 |
| IBS Invites Employers to April 8th Seminar - "What's Going on in Washington?". |
|
|
Mar 24, 2009 |
196 |
| Mr Christodoulou's lack of transparency? |
|
|
Mar 22, 2009 |
1105 |
| Salix Pharmaceuticals Reports 4Q2008 and FY2008 Results. |
|
Financial report |
Mar 10, 2009 |
3829 |
| Literature review & commentary. |
Gaby, Alan R. |
|
Jan 1, 2009 |
2314 |
| IBS is one of the commonest gut disorders. A solid doctor-patient relationship is vital in the treatment of this disorder. |
Watermeyer, Gill |
Disease/Disorder overview |
Jan 1, 2009 |
1514 |
| Early results with drug-induced "ALS": very encouraging changes while at Gerson Clinic. |
Gerson, Charlotte |
|
Jan 1, 2009 |
544 |
| Napo Pharmaceuticals Announces Publication of Paper on Crofelemer for Indication of Irritable Bowel Syndrome. |
|
|
Dec 23, 2008 |
743 |
| Probiotic Yogurt Helps Reduce Physical Bloating by up to 78%, According to New Research. |
|
|
Dec 16, 2008 |
965 |
| Cultech's new probiotic line offers irritable bowel relief. |
|
|
Dec 15, 2008 |
465 |
| Extensive work-up rarely needed to diagnose IBS. |
Walsh, Nancy |
|
Dec 15, 2008 |
625 |
| Scientists think helpful bacteria could ensure bowels run smoothly. |
|
|
Dec 11, 2008 |
327 |
| Genetic mutations implicated in irritable bowel syndrome. |
|
|
Dec 11, 2008 |
321 |
| Peppermint oil, soluble fibre 'effective in treating irritable bowel syndrome'. |
|
|
Dec 3, 2008 |
265 |
| Avoid extensive work-up for IBS. |
Walsh, Nancy |
|
Dec 1, 2008 |
672 |
| Peppermint oil, soluble fibre 'effective in treating irritable bowel syndrome'. |
|
|
Nov 25, 2008 |
265 |
| Salix Announces Issuance of U.S. Patent for Rifaximin. |
|
|
Nov 18, 2008 |
383 |
| Antibiotics, antidepressants part of IBS guidelines update. |
McNamara, Damian |
Report |
Nov 15, 2008 |
940 |
| Salix Pharmaceuticals Reports 3Q2008 Results. |
|
Financial report |
Nov 5, 2008 |
2101 |
| Effect of two artichoke extracts (36_U and 36_EB) on rat ileum (with respect to bowel syndrome) and the peristaltic threshold. |
Verspohl, E.J.; Ploch, M.; Windeck, T.; Kales, M.; Schmidt, T.; Bauer, K. |
Report |
Nov 1, 2008 |
3351 |
| Ironwood Presents Positive Phase 2b Study Results for Linaclotide in Patients with Irritable Bowel Syndrome with Constipation. |
|
Clinical report |
Oct 21, 2008 |
1082 |
| The effective management of chronic constipation and IBS-C. |
|
Disease/Disorder overview |
Oct 15, 2008 |
1717 |
| Tegaserod's CV risk may have been exaggerated. |
Jancin, Bruce |
|
Oct 15, 2008 |
765 |
| Salix Presents New Phase II Data Evidence Demonstrating the Clinical Utility of Rifaximin in Irritable Bowel Syndrome (IBS). |
|
|
Oct 6, 2008 |
1946 |
| Louis and Barbara Perlmutter Donate $5 Million to Brandeis International Business School To Establish Institute for Global Business Leadership. |
|
|
Oct 1, 2008 |
796 |
| Doctors told my Yvonne she had irritable bowel syndrome... she died five days after they realised it was stomach cancer; HOSPITAL: Fiance tells of shock diagnosis, followed by rapid deterioration. |
|
|
Sep 23, 2008 |
430 |
| Carrefour ME implemented Soft Solutions' ibs CATEGORY and ibs DEALS to enhance the development and implementation of Category Management Strategies and Supplier Negotiation. |
|
|
Sep 15, 2008 |
518 |
| Novel Collaborative Educational Initiative on Constipation to Supply Patient-Level Outcomes Data to Multidisciplinary Providers. |
|
|
Sep 3, 2008 |
955 |
| LEXICON SUCCESSFULLY COMPLETES PAHSE I STUDY OF LX1031. |
|
|
Sep 1, 2008 |
757 |
| Tricyclics and SSRIs show efficacy for treatment of irritable bowel syndrome. |
Zamosky, Lisa |
|
Sep 1, 2008 |
620 |
| Irritable bowel syndrome. |
Watermeyer, Gill |
Disease/Disorder overview |
Sep 1, 2008 |
1382 |
| Antidepressants show promise for IBS treatment. |
Zamosky, Lisa |
Clinical report |
Aug 15, 2008 |
634 |
| Salix Pharmaceuticals Reports 2Q2008 Results. |
|
Financial report |
Aug 4, 2008 |
1722 |
| Callisto Pharmaceuticals Announces $3.0 Million Financing by Its Synergy Pharmaceuticals Subsidiary and Related Transactions Leaving Callisto with a 68% Stake in Synergy. |
|
|
Jul 21, 2008 |
1090 |
| Uncovering the link between irritable bowel syndrome and abuse: irritable bowel syndrome is a largely female problem, with physical, emotional or sexual abuse often factors underlying the condition. Nurses are often in a unique position to identify links between ill health and abuse. |
Moore, Judy |
|
Jul 1, 2008 |
1899 |
| Restricting dietary fructose, fructans may improve IBS. |
Moon, Mary Ann |
|
Jul 1, 2008 |
721 |
| Salix Initiates Phase 3 For Rifaximin in Non-Constipation Irritable Bowel Syndrome. |
|
|
Jun 30, 2008 |
1262 |
| Callisto Pharmaceuticals Opens Phase I Clinical Trial of SP-304 to Treat Chronic Constipation and Irritable Bowel Syndrome. |
|
|
Jun 4, 2008 |
814 |
| Amitiza indication expanded. |
|
Brief article |
Jun 1, 2008 |
241 |
| Activia and other yogurt touted as digestive cures may make digestive problems worse. |
|
Report |
Jun 1, 2008 |
829 |
| AMITIZA(R) (lubiprostone) 8 mcg Now Available to Treat Irritable Bowel Syndrome with Constipation in Adult Women. |
|
|
May 27, 2008 |
1048 |
| Dynogen Presents Results of Its Positive Phase 2 IBS-d Study with DDP225. |
|
|
May 20, 2008 |
859 |
| Salix Presents New Rifaximin Phase IIb Data Demonstrating Significant and Sustained Improvement in Diarrhea-Associated Irritable Bowel Syndrome (D-IBS). |
|
|
May 20, 2008 |
1488 |
| Dynogen Presents Results of Its Positive Phase 2a IBS-c Study with DDP733. |
|
Clinical report |
May 20, 2008 |
793 |
| New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C). |
|
|
May 19, 2008 |
1237 |
| Altered brain response seen in IBS patients. |
Johnson Kate |
|
May 1, 2008 |
250 |
| More restrictions added to irritable bowel drug. |
Haas, Joseph |
|
May 1, 2008 |
263 |
| Dynogen to Present Positive Clinical Data for DDP225 and DDP733 at Digestive Disease Week 2008 Conference. |
|
Conference news |
Apr 30, 2008 |
958 |
| Sucampo Pharmaceuticals Obtains FDA Approval for AMITIZA(R) for the Treatment of Irritable Bowel Syndrome with Constipation in Adult Women. |
|
|
Apr 29, 2008 |
1791 |
| Tegaserod for IBS gets additional restrictions. |
Haas, Joseph |
|
Apr 15, 2008 |
325 |
| Novartis further curbs Zelnorm use. |
|
|
Apr 8, 2008 |
442 |
| Callisto Pharmaceuticals Files IND for SP-304 (Guanilib) in Chronic Constipation and Irritable Bowel Syndrome. |
|
|
Apr 7, 2008 |
864 |
| Hypnosis hailed as IBS 'cure'. |
|
|
Mar 25, 2008 |
117 |
| Hypnosis hailed as IBS 'cure'. |
|
|
Mar 25, 2008 |
157 |
| Salix Pharmaceuticals Reports 4Q2007 and FY2007 Results. |
|
|
Mar 3, 2008 |
3605 |
| ASK THE EXPERTS. |
|
|
Feb 25, 2008 |
444 |
